Lipoprotein carriers of microRNAs

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1861, Issue 12, 2016, Pages 2069-2074

  Michell, Danielle L ^a   Vickers, Kasey C ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Extracellular microRNA; HDL; Lipoproteins; microRNA

Indexed keywords

BIOLOGICAL MARKER; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; MICRORNA; MICRORNA 223; MICRORNA 24; MICRORNA 486; MICRORNA 92A; UNCLASSIFIED DRUG; INTERMEDIATE DENSITY LIPOPROTEIN;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; HEART INFARCTION; HUMAN; HYPERCHOLESTEROLEMIA; NONHUMAN; PRIORITY JOURNAL; RNA TRANSPORT; UNSTABLE ANGINA PECTORIS; ANIMAL; GENETICS; LIPID METABOLISM;

ANIMALS; CORONARY ARTERY DISEASE; HUMANS; LIPID METABOLISM; LIPOPROTEINS, HDL; LIPOPROTEINS, IDL; MICRORNAS;

EID: 84956599152     PISSN: 13881981     EISSN: 18792618     Source Type: Journal    
DOI: 10.1016/j.bbalip.2016.01.011     Document Type: Article

References (42)

1. [1] Bartel, D.P., MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116 (2004), 281–297.
2. [2] Boon, R.A., Vickers, K.C., Intercellular transport of microRNAs. Arterioscler. Thromb. Vasc. Biol. 33 (2013), 186–192.
3. [3] Vickers, K.C., Remaley, A.T., Lipid-based carriers of microRNAs and intercellular communication. Curr. Opin. Lipidol. 23 (2012), 91–97.
4. [4] Etheridge, A., Lee, I., Hood, L., Galas, D., Wang, K., Extracellular microRNA: a new source of biomarkers. Mutat. Res. 717 (2011), 85–90.
5. [5] Turchinovich, A., Weiz, L., Langheinz, A., Burwinkel, B., Characterization of extracellular circulating microRNA. Nucleic Acids Res. 39 (2011), 7223–7233.
6. [6] Tzimagiorgis, G., Michailidou, E.Z., Kritis, A., Markopoulos, A.K., Kouidou, S., Recovering circulating extracellular or cell-free RNA from bodily fluids. Cancer Epidemiol. 35 (2011), 580–589.
7. [7] Turchinovich, A., Weiz, L., Burwinkel, B., Extracellular miRNAs: the mystery of their origin and function. Trends Biochem. Sci. 37 (2012), 460–465.
8. [8] Mathivanan, S., Ji, H., Simpson, R.J., Exosomes: extracellular organelles important in intercellular communication. J. Proteome 73 (2010), 1907–1920.
9. [9] Lotvall, J., Valadi, H., Cell to cell signalling via exosomes through esRNA. Cell Adhes. Migr. 1 (2007), 156–158.
10. [10] Simons, M., Raposo, G., Exosomes—vesicular carriers for intercellular communication. Curr. Opin. Cell Biol. 21 (2009), 575–581.
11. [11] Zomer, A., Vendrig, T., Hopmans, E.S., van Eijndhoven, M., Middeldorp, J.M., Pegtel, D.M., Exosomes: fit to deliver small RNA. Commun. Integr. Biol. 3 (2010), 447–450.
12. [12] Ramachandran, S., Palanisamy, V., Horizontal transfer of RNAs: exosomes as mediators of intercellular communication. Wiley Interdiscip.Rev. RNA 3 (2012), 286–293.
13. [13] Aatonen, M., Gronholm, M., Siljander, P.R., Platelet-derived microvesicles: multitalented participants in intercellular communication. Semin. Thromb. Hemost. 38 (2012), 102–113.
14. [14] Cantaluppi, V., Gatti, S., Medica, D., Figliolini, F., Bruno, S., Deregibus, M.C., Sordi, A., Biancone, L., Tetta, C., Camussi, G., Microvesicles derived from endothelial progenitor cells protect the kidney from ischemia–reperfusion injury by microRNA-dependent reprogramming of resident renal cells. Kidney Int. 82 (2012), 412–427.
15. [15] Hulsmans, M., Holvoet, P., MicroRNA-containing microvesicles regulating inflammation in association with atherosclerotic disease. Cardiovasc. Res., 2013.
16. [16] Zernecke, A., Bidzhekov, K., Noels, H., Shagdarsuren, E., Gan, L., Denecke, B., Hristov, M., Koppel, T., Jahantigh, M.N., Lutgens, E., Wang, S., Olson, E.N., Schober, A., Weber, C., Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection. Sci. Signal., 2, 2009, ra81.
17. [17] Arroyo, J.D., Chevillet, J.R., Kroh, E.M., Ruf, I.K., Pritchard, C.C., Gibson, D.F., Mitchell, P.S., Bennett, C.F., Pogosova-Agadjanyan, E.L., Stirewalt, D.L., Tait, J.F., Tewari, M., Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc. Natl. Acad. Sci. U. S. A. 108 (2011), 5003–5008.
18. [18] Turchinovich, A., Burwinkel, B., Distinct AGO1 and AGO2 associated miRNA profiles in human cells and blood plasma. RNA Biol. 9 (2012), 1066–1075.
19. [19] Lee, H., Kim, S.I., Shin, D., Yoon, Y., Choi, T.H., Cheon, G.J., Kim, M., Hepatic siRNA delivery using recombinant human apolipoprotein A-I in mice. Biochem. Biophys. Res. Commun. 378 (2009), 192–196.
20. [20] Vickers, K.C., Palmisano, B.T., Shoucri, B.M., Shamburek, R.D., Remaley, A.T., MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat. Cell Biol. 13 (2011), 423–433.
21. [21] Wagner, J., Riwanto, M., Besler, C., Knau, A., Fichtlscherer, S., Roxe, T., Zeiher, A.M., Landmesser, U., Dimmeler, S., Characterization of levels and cellular transfer of circulating lipoprotein-bound microRNAs. Arterioscler. Thromb. Vasc. Biol. 33 (2013), 1392–1400.
22. [22] Skipski, V.P., Barclay, M., Barclay, R.K., Fetzer, V.A., Good, J.J., Archibald, F.M., Lipid composition of human serum lipoproteins. Biochem. J. 104 (1967), 340–352.
23. [23] Kontush, A., Lindahl, M., Lhomme, M., Calabresi, L., Chapman, M.J., Davidson, W.S., Structure of HDL: particle subclasses and molecular components. Handb. Exp. Pharmacol. 224 (2015), 3–51.
24. [24] Toth, P.P., Barter, P.J., Rosenson, R.S., Boden, W.E., Chapman, M.J., Cuchel, M., D'Agostino, R.B. Sr., Davidson, M.H., Davidson, W.S., Heinecke, J.W., Karas, R.H., Kontush, A., Krauss, R.M., Miller, M., Rader, D.J., High-density lipoproteins: a consensus statement from the National Lipid Association. J. Clin. Lipidol. 7 (2013), 484–525.
25. [25] Niculescu, L.S., Simionescu, N., Sanda, G.M., Carnuta, M.G., Stancu, C.S., Popescu, A.C., Popescu, M.R., Vlad, A., Dimulescu, D.R., Simionescu, M., Sima, A.V., MiR-486 and miR-92a identified in circulating HDL discriminate between stable and vulnerable coronary artery disease patients. PLoS ONE, 10, 2015, e0140958.
26. [26] Loyer, X., Potteaux, S., Vion, A.C., Guerin, C.L., Boulkroun, S., Rautou, P.E., Ramkhelawon, B., Esposito, B., Dalloz, M., Paul, J.L., Julia, P., Maccario, J., Boulanger, C.M., Mallat, Z., Tedgui, A., Inhibition of microrna-92a prevents endothelial dysfunction and atherosclerosis in mice. Circ. Res. 114 (2014), 434–443.
27. [27] Schober, A., Nazari-Jahantigh, M., Wei, Y., Bidzhekov, K., Gremse, F., Grommes, J., Megens, R.T., Heyll, K., Noels, H., Hristov, M., Wang, S., Kiessling, F., Olson, E.N., Weber, C., MicroRNA-126-5p promotes endothelial proliferation and limits atherosclerosis by suppressing Dlk1. Nat. Med. 20 (2014), 368–376.
28. [28] Son, D.J., Kumar, S., Takabe, W., Kim, C.W., Ni, C.W., Alberts-Grill, N., Jang, I.H., Kim, S., Kim, W., Won Kang, S., Baker, A.H., Woong Seo, J., Ferrara, K.W., Jo, H., The atypical mechanosensitive microRNA-712 derived from pre-ribosomal RNA induces endothelial inflammation and atherosclerosis. Nat. Commun., 4, 2013, 3000.
29. [29] Hergenreider, E., Heydt, S., Treguer, K., Boettger, T., Horrevoets, A.J., Zeiher, A.M., Scheffer, M.P., Frangakis, A.S., Yin, X., Mayr, M., Braun, T., Urbich, C., Boon, R.A., Dimmeler, S., Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs. Nat. Cell Biol. 14 (2012), 249–256.
30. [30] Tabet, F., Vickers, K.C., Cuesta Torres, L.F., Wiese, C.B., Shoucri, B.M., Lambert, G., Catherinet, C., Prado-Lourenco, L., Levin, M.G., Thacker, S., Sethupathy, P., Barter, P.J., Remaley, A.T., Rye, K.A., HDL-transferred microRNA-223 regulates ICAM-1 expression in endothelial cells. Nat. Commun., 5, 2014, 3292.
31. [31] Van Lenten, B.J., Hama, S.Y., de Beer, F.C., Stafforini, D.M., McIntyre, T.M., Prescott, S.M., La Du, B.N., Fogelman, A.M., Navab, M., Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures. J. Clin. Invest. 96 (1995), 2758–2767.
32. [32] Van Lenten, B.J., Navab, M., Shih, D., Fogelman, A.M., Lusis, A.J., The role of high-density lipoproteins in oxidation and inflammation. Trends Cardiovasc. Med. 11 (2001), 155–161.
33. [33] Ansell, B.J., Navab, M., Watson, K.E., Fonarow, G.C., Fogelman, A.M., Anti-inflammatory properties of HDL. Rev. Endocr. Metab. Disord. 5 (2004), 351–358.
34. [34] Cockerill, G.W., Rye, K.A., Gamble, J.R., Vadas, M.A., Barter, P.J., High-density lipoproteins inhibit cytokine-induced expression of endothelial cell adhesion molecules. Arterioscler. Thromb. Vasc. Biol. 15 (1995), 1987–1994.
35. [35] Vickers, K.C., Remaley, A.T., HDL and cholesterol: life after the divorce?. J. Lipid Res., 2013.
36. [36] Rosenson, R.S., Brewer, H.B. Jr., Ansell, B.J., Barter, P., Chapman, M.J., Heinecke, J.W., Kontush, A., Tall, A.R., Webb, N.R., Dysfunctional HDL and atherosclerotic cardiovascular disease. Nat. Rev. Cardiol. 13 (2016), 48–60.
37. [37] Kaseda, R., Jabs, K., Hunley, T.E., Jones, D., Bian, A., Allen, R.M., Vickers, K.C., Yancey, P.G., Linton, M.F., Fazio, S., Kon, V., Dysfunctional high-density lipoproteins in children with chronic kidney disease. Metab. Clin. Exp. 64 (2015), 263–273.
38. [38] Vickers, K.C., Shoucri, B.M., Levin, M.G., Wu, H., Pearson, D.S., Osei-Hwedieh, D., Collins, F.S., Remaley, A.T., Sethupathy, P., MicroRNA-27b is a regulatory hub in lipid metabolism and is altered in dyslipidemia. Hepatology 57 (2013), 533–542.
39. [39] Vickers, K.C., Landstreet, S.R., Levin, M.G., Shoucri, B.M., Toth, C.L., Taylor, R.C., Palmisano, B.T., Tabet, F., Cui, H.L., Rye, K.A., Sethupathy, P., Remaley, A.T., MicroRNA-223 coordinates cholesterol homeostasis. Proc. Natl. Acad. Sci. U. S. A. 111 (2014), 14518–14523.
40. [40] Lai, L., Song, Y., Liu, Y., Chen, Q., Han, Q., Chen, W., Pan, T., Zhang, Y., Cao, X., Wang, Q., MicroRNA-92a negatively regulates toll-like receptor (TLR)-triggered inflammatory response in macrophages by targeting MKK4 kinase. J. Biol. Chem. 288 (2013), 7956–7967.
41. [41] Liu, D., Zhang, M., Xie, W., Lan, G., Cheng, H.P., Gong, D., Huang, C., Lv, Y.C., Yao, F., Tan, Y.L., Li, L., Zheng, X.L., Tang, C.K., MiR-486 regulates cholesterol efflux by targeting HAT1. Biochem. Biophys. Res. Commun., 2015.
42. [42] Fordham, J.B., Naqvi, A.R., Nares, S., Regulation of miR-24, miR-30b, and miR-142-3p during macrophage and dendritic cell differentiation potentiates innate immunity. J. Leukoc. Biol. 98 (2015), 195–207.